Regen BioPharma, Inc. Director Of Molecular Therapeutics To Speak At Stem Cell Conference Regarding Leukemia Research Being Conducted By The Company

Regen BioPharma, Inc., (OTCBB: RGBP) and (PINK: RGBP) announced today that Dr. Christine Ichim, Director of Molecular Therapeutics at Regen, was selected by the organizers of Stem Cell Meeting on the Mesa to speak at the conference regarding ongoing …

[Read the full article here]

Comments are closed.